[1]
|
Sebastian Domingo, J.J. (2022) Irritable Bowel Syndrome. Medicina Clínica (English Edition), 158, 76-81.
https://doi.org/10.1016/j.medcle.2021.04.015
|
[2]
|
Lacy, B.E. and Patel, N.K. (2017) Rome Criteria and a Diagnos-tic Approach to Irritable Bowel Syndrome. Journal of Clinical Medicine, 6, 99-106. https://doi.org/10.3390/jcm6110099
|
[3]
|
韩亚飞, 王允亮, 李军祥. 腹泻型肠易激综合征发病机制及中药干预研究进展[J]. 辽宁中医药大学学报, 2018, 20(1): 114-117.
|
[4]
|
汪龙德, 张萍, 任培培, 等. 腹泻型肠易激综合征相关发病机制及治疗的研究进展[J]. 实用中医内科杂志, 2022, 36(1): 16-19.
|
[5]
|
王彬, 赵威, 许梦雀, 等. 肠易激综合征患者睡眠质量和精神心理状况的调查[J]. 胃肠病学, 2018, 23(3): 161-165.
|
[6]
|
Oka, P., Parr, H., Bar-berio, B., et al. (2020) Global Prevalence of Irritable Bowel Syndrome According to Rome III or IV Criteria: A System-atic Review and Meta-Analysis. The Lancet Gastroenterology & Hepatology, 5, 908-917.
https://doi.org/10.1016/S2468-1253(20)30217-X
|
[7]
|
Mearin, F., Lacy, B.E., Chang, L., et al. (2016) Bowel Dis-orders. Gastroenterology.
|
[8]
|
张声生, 魏玮, 杨俭勤. 肠易激综合征中医诊疗专家共识意见(2017) [J]. 中医杂志, 2017, 58(18): 1614-1620.
|
[9]
|
张艳霞, 赵蓉, 吕双然, 等. 腹泻型肠易激综合征中医证候分布与VIP, SP, 5-HT动态变化的相关性分析[J]. 河北中医药学报, 2022, 37(1): 17-20.
|
[10]
|
左军, 张金龙, 胡晓阳. 白术化学成分及现代药理作用研究进展[J]. 辽宁中医药大学学报, 2021, 23(10): 6-9.
|
[11]
|
邓桃妹, 彭代银, 俞年军, 等. 茯苓化学成分和药理作用研究进展及质量标志物的预测分析[J]. 中草药, 2020, 51(10): 2703-2717.
|
[12]
|
张燕丽, 孟凡佳, 田园, 等. 炙甘草的化学成分与药理作用研究进展[J]. 化学工程师, 2019, 33(8): 60-63+66.
|
[13]
|
邵礼梅, 许世伟. 山药化学成分及现代药理研究进展[J]. 中医药学报, 2017, 45(2): 125-127.
|
[14]
|
Mmcs, J., et al. (2023) Al-pha-Ketoglutaric Acid Based Polymeric Particles for Cutaneous Wound Healing. Journal of Biomedical Materials Re-search Part A, 111, 1372-1378.
|
[15]
|
He, L., Huang, N., Li, H., et al. (2017) AMPK/α-Ketoglutarate Axis Regulates In-testinal Water and Ion Homeostasis in Young Pigs. Journal of Agricultural and Food Chemistry, 65, 2287-2298. https://doi.org/10.1021/acs.jafc.7b00324
|
[16]
|
Camilleri, M. (2019) Implications of Pharmacogenomics to the Man-agement of IBS. Clinical Gastroenterology and Hepatology, 17, 584-594. https://doi.org/10.1016/j.cgh.2018.04.052
|
[17]
|
Puszkiel, A., Arellano, C., Vachoux, C., et al. (2021) Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical Pharmacology & Therapeutics, 109, 1244-1255. https://doi.org/10.1002/cpt.2077
|
[18]
|
Liu, J., Lu, Y.F., Corton, J.C., et al. (2021) Expression of Cytochrome P450 Isozyme Transcripts and Activities in Human Livers. Xenobiotica, 51, 279-286. https://doi.org/10.1080/00498254.2020.1867929
|
[19]
|
Yi, Y.L., Li, Y., Guo, S., et al. (2022) Elucidation of the Reinforcing Spleen Effect of Jujube Fruits Based on Metabolomics and Intestinal Flora Analysis. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 847828.
https://doi.org/10.3389/fcimb.2022.847828
|
[20]
|
Effendi, W.I. and Nagano, T. (2023) A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International Journal of Molecular Sciences, 24, Article No. 4428.
https://doi.org/10.3390/ijms24054428
|
[21]
|
刘汝霏, 吴萌, 尚杰. 单磷酸腺苷活化蛋白激酶通过调控能量代谢对肿瘤发挥双重作用的研究进展[J]. 中华肿瘤防治杂志, 2023, 30(17): 1069-1078.
|
[22]
|
De Lera Ruiz, M., Lim, Y.H. and Zheng, J. (2014) Adenosine A2A Receptor as a Drug Discovery Target. Journal of Medicinal Chemistry, 57, 3623-3650. https://doi.org/10.1021/jm4011669
|
[23]
|
Effendi, W.I., Nagano, T., Kobayashi, K., et al. (2020) Focus-ing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells, 9, Article No. 785. https://doi.org/10.3390/cells9030785
|
[24]
|
Ishioh, M., et al. (2021) Activation of Central Adenosine A2B Receptors Mediate Brain Ghrelin-Induced Improvement of Intestinal Barrier Function through the Vagus Nerve in Rats. Experi-mental Neurology, 341, Article ID: 113708.
https://doi.org/10.1016/j.expneurol.2021.113708
|